Protein Immunoblotting and Apoptosis Assay

Immunoblotting and immunofluorescence were performed as previously described.^{13 (link)} Antibodies are listed in Supplementary Table S1. Human apoptosis array kit was performed per the manufacturer's instructions (ARY009, R&D Systems).

Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link: Access Free Full Text.

Zisi A., Kanellis D.C., Moussaud S., Karlsson I., Carén H., Bräutigam L., Bartek J, & Lindström M.S. (2022). Small molecule-mediated disruption of ribosome biogenesis synergizes with FGFR inhibitors to suppress glioma cell growth. Neuro-Oncology, 25(6), 1058-1072.

Publication 2022

ARY009

Antibodies Apoptosis Human Immunofluorescence

Corresponding Organization : Danish Cancer Society

Other organizations : University of Gothenburg

Top 5 similar protocols

Variable analysis

independent variables

Immunoblotting and immunofluorescence procedures

dependent variables

Protein expression and localization as measured by immunoblotting and immunofluorescence

control variables

Immunoblotting and immunofluorescence procedures were performed as previously described
Antibodies used are listed in Supplementary Table S1

controls

Positive control: Not specified
Negative control: Not specified

Annotations

Based on most similar protocols

Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.

As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!